Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Lyra Therapeutics revenue
Lyra Therapeutics's revenue is $1.5 million.
What is Lyra Therapeutics's revenue?
- Lyra Therapeutics's revenue growth from 2021 to 2024 is 438.25%.
- Lyra Therapeutics has 60 employees, and the revenue per employee ratio is $25,566.
- Lyra Therapeutics's peak quarterly revenue was $598.0K in 2024(q2).
- Lyra Therapeutics peak revenue was $1.6M in 2023.
- Lyra Therapeutics annual revenue for 2023 was 1.6M, 14.31% growth from 2022.
- Lyra Therapeutics annual revenue for 2024 was 1.5M, -1.54% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Lyra Therapeutics historical revenue
Lyra Therapeutics annual revenue
Lyra Therapeutics annual revenue over time
| Fiscal year / year | Lyra Therapeutics revenue |
|---|---|
| 2021 | $285,000 |
| 2022 | $1.4M |
| 2023 | $1.6M |
| 2024 | $1.5M |
How accurately did Lyra Therapeutics' revenue projections match actual performance?
Lyra Therapeutics annual growth
Lyra Therapeutics annual growth rate over time
| Year | Lyra Therapeutics growth |
|---|---|
| 2022 | 378%↑ |
| 2023 | 14%↑ |
| 2024 | -2%↓ |
Lyra Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Lyra Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | - | $14,000 | $271,000 |
| 2022 | $468,000 | $525,000 | $359,000 | $11,000 |
| 2023 | $410,000 | $458,000 | $544,000 | $146,000 |
| 2024 | $532,000 | $598,000 | $195,000 | $209,000 |
Lyra Therapeutics jobs nearby
Do you work at Lyra Therapeutics?
Is Lyra Therapeutics transparent about its revenue structure?
Lyra Therapeutics financing
Lyra Therapeutics received early financing of $29.5M on 2018-09-26.
| Series | Round size | Date |
|---|---|---|
| Series B | $29.5M | 09/2018 |
| Series C | $30M | 01/2020 |
Lyra Therapeutics investors
| Investors | Security type |
|---|---|
| Intersouth Partners | Series B |
| Broadview Ventures Inc | Series B |
| Soleus Capital LLC | Series B |
| Perceptive Advisors | Series B |
| ArrowMark Partners | Series B |
| North Bridge Venture Partners | Series B |
| RA Capital Management | Series B |
| Polaris Venture Capital | Series B |
| Polaris Partners | Series C |
| Intersouth Partners | Series C |
| Soleus Capital LLC | Series C |
| Perceptive Advisors | Series C |
| ArrowMark Partners | Series C |
| North Bridge Venture Partners | Series C |
| RA Capital Management | Series C |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Lyra Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lyra Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Lyra Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Lyra Therapeutics. The data presented on this page does not represent the view of Lyra Therapeutics and its employees or that of Zippia.
Lyra Therapeutics may also be known as or be related to LYRA THERAPEUTICS, INC., Lyra Therapeutics and Lyra Therapeutics, Inc.